[1]
“755 Evolution of Functional and Paraclinical Markers as Predictive Factors in Pediatric Late-Onset SMA Under Nusinersen Treatment: The Role of CSF pNF-H”, Balneo, vol. 15, no. 4, Feb. 2025, Accessed: Aug. 11, 2026. Available: https://bioclima.ro/Journal/index.php/BRJ/article/view/438